Three-Year Observational Study on the Long-Term Efficacy and Safety of Dupilumab in Elderly Patients with Severe Atopic Dermatitis

Clin Exp Dermatol. 2024 Oct 10:llae420. doi: 10.1093/ced/llae420. Online ahead of print.
No abstract available